The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior

Phase 2 Completed 62 enrolled Yale University National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to examine how smoking cessation medications (varenicline, bupropion) affect the ability to resist smoking and also subsequent ad-lib smoking in non-treatment seeking daily smokers.

Timeline

Start: 2007-04
Primary completion: 2016-10
Completion: 2016-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bupropion	Small molecule	300 mg	—
Subject	Varenicline	Small molecule	2 mg	—

Indications

No indication recorded.